ACADIA Pharmaceuticals
Committed to developing treatments for neurological disorders.
Launch date
Employees
Market cap
€2.5b
Enterprise valuation
€2.1b (Public information from Sep 2024)
Share price
$16.42 ACAD
San Diego California (HQ)
Authorizing premium user...